More people are living with severe obesity, and weight-loss medication is being used widely. But what does that mean for overall health beyond weight loss? A new study… read more.
Misuse of stimulant medications for attention deficit hyperactivity disorder (ADHD) has declined sharply. In 2023, approximately 3.7% of adults under age 30 misused these medications, down from 7.5%… read more.
Pfizer Inc. announced the FDA approved Ibrance (palbociclib) in combination with trastuzumab, with or without pertuzumab, and endocrine therapy for the maintenance treatment of adult patients with hormone… read more.
Emergency Medicine & Intensive Care
Forty per cent of women with ovarian cancer only receive a diagnosis after an emergency hospital admission, a new study reports. Ovarian cancer detected following an emergency admission is more likely to be at an advanced stage, with… read more.
People diagnosed with early-onset dementia had reduced work productivity up to 15 years before diagnosis, according to a study published July 8, 2026, in Neurology®, the medical journal of… read more.
A new study published in JAMA has found that insurance formulary rejections of single-source branded drugs are common in the United States and often leave patients without timely… read more.
Eisai Co., Ltd. announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom has validated the Marketing Authorisation Application (MAA) for taletrectinib for the… read more.
Medicare prescriptions for Wegovy increased sharply after the program started covering the anti-obesity medication to prevent heart problems, but just a fraction of beneficiaries likely eligible received the… read more.
United Therapeutics Corporation announced that the FDA has granted premarket approval (PMA) of the LungFXTM device (LungFX) for use in centralized ex vivo lung perfusion (EVLP), a procedure… read more.
Artificial intelligence is spreading rapidly in health care, with the goal of streamlining critical but onerous clerical tasks such as note-taking and charting so that physicians and nurses… read more.
More than 50 million Americans live with chronic pain; among them, approximately one in 10 take prescription opioids regularly. A new large-scale study led by Stanford Medicine suggests… read more.
The FDA has approved subcutaneous (SC) Sarclisa (isatuximab-irfc) Escena in combination with standard-of-care regimens for the treatment of patients with multiple myeloma (MM) across all existing indications of… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
